|
RVX-208 Ameliorates Peridontal Bone Loss
|
8
|
Resverlogix Corp.
|
May 24, 2018 10:17AM
|
|
American Society of Nephrology Kidney Week
|
8
|
Resverlogix Corp.
|
Oct 18, 2017 02:19PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
8
|
Resverlogix Corp.
|
Sep 14, 2017 10:18AM
|
|
Re: Gran Oso.....
|
8
|
Resverlogix Corp.
|
Jan 23, 2020 08:36PM
|
|
Re: Loan Agreement
|
8
|
Resverlogix Corp.
|
May 17, 2018 05:07PM
|
|
RVX in Austria for ERA/EDTA and EAS
|
8
|
Resverlogix Corp.
|
May 17, 2016 05:14PM
|
|
Re: Not predicting another short attack....
|
8
|
Resverlogix Corp.
|
Aug 23, 2018 02:15PM
|
|
Re: Roth research report
|
8
|
Resverlogix Corp.
|
Oct 31, 2018 10:20PM
|
|
Re: eGFR and Cognition?
|
8
|
Resverlogix Corp.
|
Nov 23, 2019 07:20AM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
8
|
Resverlogix Corp.
|
Sep 03, 2019 08:36PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
8
|
Resverlogix Corp.
|
Aug 02, 2019 02:48PM
|
|
Re: Did someone already post this?
|
8
|
Resverlogix Corp.
|
Aug 17, 2017 11:26AM
|
|
Re: What an incredible...
|
8
|
Resverlogix Corp.
|
Dec 23, 2019 01:15PM
|
|
Re: Brilinta-AZ
|
8
|
Resverlogix Corp.
|
Apr 19, 2018 12:36PM
|
|
Re: Can't you feel the excitment?
|
8
|
Resverlogix Corp.
|
Aug 16, 2019 06:48AM
|
|
BETonMACE ClinicalTrials.gov update
|
8
|
Resverlogix Corp.
|
Jul 20, 2019 08:46AM
|
|
Recent presentations
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 11:00AM
|
|
Zenith AGM webcast 9/12/2018
|
8
|
Zenith Epigenetics
|
Sep 10, 2018 05:56PM
|
|
Resverlogix AGM webcast 9/12/2018
|
8
|
Resverlogix Corp.
|
Sep 10, 2018 06:03PM
|
|
Re: Next private placement/licensing agreement
|
8
|
Resverlogix Corp.
|
Feb 06, 2019 12:29PM
|
